Dipeptidyl Peptidase IV  Inhibitors market

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size, Share - Global Outlook and Forecast 2022-2028

  • 08 February 2022
  • Life Sciences
  • 79 Pages
  • Report code : PMR-6845466

  • 4.7 (158)

Dipeptidyl Peptidase IV Inhibitors Market

COMPANIES COVERED

AstraZeneca
Boehringer
Eli Lilly
Merck
Mitsubishi Tanabe Pharma
Novartis
Takeda

Download FREE Report Sample

  Download Free sample

Dipeptidyl peptidase-4 (DPP-4) inhibitors are a relatively new class of oral diabetes drugs. Also known as gliptins, they are usually prescribed for people with type 2 diabetes who have not responded well to drugs such as metformin and sulphonylureas

Dipeptidyl Peptidase IV Inhibitors Market contains market size and forecasts of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in global, including the following market information:

  • Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Revenue, 2017-2022, 2023-2028, ($ millions)
  • Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Sales, 2017-2022, 2023-2028, (K MT)
  • Global top five Dipeptidyl Peptidase IV (DPP-IV) Inhibitors companies in 2021 (%)

The global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Sitagliptin Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors include AstraZeneca, Boehringer, Eli Lilly, Merck, Mitsubishi Tanabe Pharma, Novartis and Takeda, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Segment Percentages, by Type, 2021 (%)

  • Sitagliptin
  • Vildagliptin
  • Saxagliptin
  • Linagliptin
  • Others
  • Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K MT)
  • Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Segment Percentages, by Application, 2021 (%)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies

Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K MT)

Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Segment Percentages, By Region and Country, 2021 (%)

  • North America
  • US
  • Canada
  • Mexico
  • Europe
  • Germany
  • France
  • U.K.
  • Italy
  • Russia
  • Nordic Countries
  • Benelux
  • Rest of Europe
  • Asia
  • China
  • Japan
  • South Korea
  • Southeast Asia
  • India
  • Rest of Asia
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Middle East & Africa
  • Turkey
  • Israel
  • Saudi Arabia
  • UAE
  • Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

  • Key companies Dipeptidyl Peptidase IV (DPP-IV) Inhibitors revenues in global market, 2017-2022 (Estimated), ($ millions)
  • Key companies Dipeptidyl Peptidase IV (DPP-IV) Inhibitors revenues share in global market, 2021 (%)
  • Key companies Dipeptidyl Peptidase IV (DPP-IV) Inhibitors sales in global market, 2017-2022 (Estimated), (K MT)
  • Key companies Dipeptidyl Peptidase IV (DPP-IV) Inhibitors sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

  • AstraZeneca
  • Boehringer
  • Eli Lilly
  • Merck
  • Mitsubishi Tanabe Pharma
  • Novartis
  • Takeda

CHECK TODAYS BEST PRICE

BEST PRICE: $2275
Buy Full Report

Select Licence type with your requirement and needs

SECURITY ASSUREDpayment image

analyst icon
Still not found what you want?

Speak to our Custom Research Team and get the Custom Research in a budget

Custom Research


Frequently Asked Questions ?

  • A license granted to one user.

    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License

    A license granted to multiple users.

  • Site License

    A license granted to a single business site/establishment.

  • Corporate License, Global License

    A license granted to all employees within organisation access to the product.

  • Upto Working 24 to 48 hrs

  • Upto 72 hrs max - Weekends and Public Holidays

  • Online Payments with PayPal and CCavenue

  • Wire Transfer/Bank Transfer

  • Email

  • Hard Copy

WHY CHOOSE US

  • Proactive We manage our resources 24/7 to identify issues and address them before they become problems
  • Quality & Reliability We are committed to providing reliable and highly accurate data with an excellent quality control system
  • Global Outreach 6 Major regions and 40+ countries level analysis accomplished
  • Competitive Pricing Our pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery

SAMPLE REPORT INCLUDES
  • Industry Market SizeIndustry Market Size
  • SWOT AnalysisSWOT Analysis
  • Industry Major PlayersIndustry Major Players
  • Revenue ForecastsRevenue Forecasts
  • Historical and Forecast GrowthHistorical and Forecast Growth
  • Profitability AnalysisProfitability Analysis
SOME OF OUR CLIENTS
WHAT SET US APART?
  • quilty

    Quality Assurance

    Focus on Data Accuracy & Reliability
  • quilty

    Trusted by the Best

    75+ Clients in Fortune 500
  • quilty

    Privacy and Security

    All your transactions are secured end-to-end, ensuring a satisfactory purchase
  • quilty

    Competitive Pricing

    Ensure the best and affordable pricing
OUR HAPPY CUSTOMER Some of our customer review
Stay Updated About Dipeptidyl Peptidase IV Inhibitors Market

Leave This Empty: